BPI Labs does not sell directly to consumers
GIP and GLP1, the two incretin hormones: Similarities and differences Update on the effects of physical activity on insulin sensitivity in humans Circadian secretion rhythm of GLP-1 and its influencing factors Shift Work and Metabolic Syndrome Updates: A Systematic Review Medicinal Plants Qua Glucagon-Like Peptide-1 Secretagogue via Intestinal Nutrient Sensors Real Science, Real Results Get expert insights on fueling your body, supporting metabolism, and living longerdelivered to your inbox every Monday
El promedio de la prdida de peso, en 6 meses de tratamiento con 3 cpsula diarias, puede variar entre 9 y 13.5 kilogramos, mientras que la circunferencia de cintura puede reducirse 12.8 cm en promedio

Contact your GP or diabetes specialist if you experience: Severe or worsening fatigue that significantly impairs daily functioning or persists despite self-management strategies Signs of dehydration including dark urine, dizziness, rapid heartbeat, or confusion Symptoms suggesting hypoglycaemia (low blood glucose) such as shakiness, sweating, confusion, or palpitations, particularly if you take insulin or sulfonylureas Persistent nausea or vomiting preventing adequate food or fluid intake Unintentional, rapid, or concerning weight loss , or inability to maintain adequate nutrition Symptoms of nutritional deficiency including pale skin, shortness of breath, tingling in hands or feet, or muscle weakness Seek urgent medical attention if you develop: Severe, persistent abdominal pain (with or without vomiting) may indicate pancreatitis Right upper abdominal pain, fever, or yellowing of skin/eyes possible gallbladder problems Severe dehydration or significantly reduced urination risk of kidney problems Signs of allergic reaction such as rash, swelling, or difficulty breathing Your GP may recommend blood tests to assess for anaemia, thyroid function, kidney function, and other causes of fatigue based on your symptoms

Those on insulin or insulin secretagogues face heightened hypoglycemia risk and need frequent glucose monitoring and medication adjustments throughout GLP-1 titration